Alana Hippensteele, Lead Editor

Under the 2020 CARES Act that Congress passed and signed into law on March 27, the items eligible for reimbursement by FSAs and HSAs include OTC medications and menstrual products.

At ESMO 2020, researchers discussed some long-awaited data regarding postoperative radiotherapy used in patients with non-small cell lung cancer following complete resection and after (neo) adjuvant chemotherapy.

Among patients with cervical cancer, there was no significant difference found between the risk of recurrence, local recurrence, or death among individuals who either completed or abandoned a radical uterine procedure following the intraoperative detection of a positive pelvic lymph node.

A combination treatment was found to be associated with significantly less weight gain and smaller increases in waist circumference than treatment with olanzapine alone.

The predictive value provided by T effector and angiogenesis signatures were found to be augmented by Kidney Immune Classification of tumor microenvironments.

Pharmacy Times® interviewed Anne Marie Kondic, PharmD, the executive director of the Community Pharmacy Foundation, on the grant opportunities on the horizon that support the practice of pharmacy in the community setting.

In a comprehensive systematic review that assessed risk factors for HZ infection, researchers found that immunosuppression through HIV/AIDS or malignancy places individuals at a significant risk.

More than half of high-risk patients with resected, stage III BRAF V600-mutated melanoma who were treated with dabrafenib and trametinib were alive and relapse-free at 5 years.

NACDS and NASPA have been encouraging state legislators to promote the critical public health message of the importance of flu vaccination this year.

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.

Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.

When treating these diseases, immunoglobulin is effective because of its ability to be used by the immune system to neutralize pathogens, such as pathogenic bacteria, fungi, and viruses.

Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.

Understanding the role of abemaciclib (Verzenio) in managing patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer is crucial.

It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.

An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.

Bristol Myers Squibb announced it will present data from research spanning 15 different cancers with high unmet need at the ESMO Virtual Congress 2020.

Two phase 3 studies showed an investigational 15-valent pneumococcal conjugate vaccine (V114, Merck) was well-tolerated among patients and met the primary immunogenicity objectives.

Researchers at the Rensselaer Polytechnic Institute recently published a study on the use of the FDA-approved anticoagulant heparin in patients with COVID-19.

Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.

Weight loss may be able to prevent or reverse type 2 diabetes (T2D), according to research presented at the European Society of Cardiology Congress 2020.

According to results from a recent study, a functional cure for HIV may lie in identifying the viral reservoirs in which HIV places copies of its viral genetic material into cell genomes.

In a survey of nearly 2000 physicians across 31 countries, nearly half of the physicians indicated that they see significant barriers to COVID-19 vaccine adoption for themselves and their adult patients.

In a new study assessing the demographics of the groups less likely to receive the flu shot, researchers find the biggest determinants of whether an individual was vaccinated for the flu.

In a Pharmacy Times' webcast on immunization practices during the pandemic, thought leaders discussed considerations and best practices regarding the administration of vaccinations.

In a viewpoint article published in JAMA, researchers proposed reforms that could improve the authorization and approval process during public health crises to increase the public’s trust in the agency.

A recent study demonstrated the safety and clinical activity of E7 TCR-T cells in the treatment of highly refractory metastatic HPV- 16+ cancers.

The development of the COVID-19 vaccine AZD1222 has expanded into a phase 3 trial that is enrolling 30,000 adults aged 18 years or older to assess its safety, efficacy, and immunogenicity.

A recent survey showed that 86% of community pharmacists plan to offer the COVID-19 vaccines once they become available, whereas another 12% responded that they want more information to determine their decision.

Current advances in the analysis of the mutational status of different genes are providing investigators insights into new treatment pathways that can improve outcomes for patients.